108 related articles for article (PubMed ID: 14513001)
1. Investigation of PrPres in dental tissues in variant CJD.
Head MW; Ritchie D; McLoughlin V; Ironside JW
Br Dent J; 2003 Sep; 195(6):339-43; discussion 331. PubMed ID: 14513001
[TBL] [Abstract][Full Text] [Related]
2. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting.
Ritchie DL; Head MW; Ironside JW
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):360-8. PubMed ID: 15305981
[TBL] [Abstract][Full Text] [Related]
3. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.
Hill AF; Butterworth RJ; Joiner S; Jackson G; Rossor MN; Thomas DJ; Frosh A; Tolley N; Bell JE; Spencer M; King A; Al-Sarraj S; Ironside JW; Lantos PL; Collinge J
Lancet; 1999 Jan; 353(9148):183-9. PubMed ID: 9923873
[TBL] [Abstract][Full Text] [Related]
4. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.
Wadsworth JD; Joiner S; Hill AF; Campbell TA; Desbruslais M; Luthert PJ; Collinge J
Lancet; 2001 Jul; 358(9277):171-80. PubMed ID: 11476832
[TBL] [Abstract][Full Text] [Related]
6. Dental treatment and risk of variant CJD--a case control study.
Everington D; Smith AJ; Ward HJ; Letters S; Will RG; Bagg J
Br Dent J; 2007 Apr; 202(8):E19; discussion 470-1. PubMed ID: 17299423
[TBL] [Abstract][Full Text] [Related]
7. CJD PrPsc removal by nanofiltration process: application to a therapeutic immunoglobulin solution (Lymphoglobuline).
Truchot L; Arnaud T; Bloy C; Perret-Liaudet A
Biologicals; 2006 Sep; 34(3):227-31. PubMed ID: 16490361
[TBL] [Abstract][Full Text] [Related]
8. Prion diseases and dental treatment: principles and practice of patients with/suspected or at-risk of CJD: case reports.
Smith AJ; Sweeney MP; Bagg J
Br Dent J; 2003 Sep; 195(6):319-21. PubMed ID: 14512992
[TBL] [Abstract][Full Text] [Related]
9. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
10. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
Ironside JW; Head MW
Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
[TBL] [Abstract][Full Text] [Related]
11. Immunhistological evaluation of Creutzfeldt-Jakob disease with reference to the type PrPres deposition.
Tateishi J; Kitamoto T; Kretzschmar H; Mehraein P
Clin Neuropathol; 1996; 15(6):358-60. PubMed ID: 8937784
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of urinary PrPSc as a diagnostic test for sporadic, variant, and familial CJD.
Head MW; Kouverianou E; Taylor L; Green A; Knight R
Neurology; 2005 May; 64(10):1794-6. PubMed ID: 15911815
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease.
Iwasaki Y; Mimuro M; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
Neuropathology; 2008 Feb; 28(1):51-61. PubMed ID: 18181835
[TBL] [Abstract][Full Text] [Related]
14. The in vitro bioassay systems for the amplification and detection of abnormal prion PrP(Sc) in blood and tissues.
Zhang W; Wu J; Li Y; Carke RC; Wong T
Transfus Med Rev; 2008 Jul; 22(3):234-42. PubMed ID: 18572098
[TBL] [Abstract][Full Text] [Related]
15. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry.
Dabaghian RH; Barnard G; McConnell I; Clewley JP
J Virol Methods; 2006 Mar; 132(1-2):85-91. PubMed ID: 16219367
[TBL] [Abstract][Full Text] [Related]
16. Tissue safety in view of CJD and variant CJD.
Pauli G
Cell Tissue Bank; 2005; 6(3):191-200. PubMed ID: 16151959
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte contamination of laryngoscope blades--a possible vector for transmission of variant Creutzfeldt-Jakob disease.
Hirsch N; Beckett A; Collinge J; Scaravilli F; Tabrizi S; Berry S
Anaesthesia; 2005 Jul; 60(7):664-7. PubMed ID: 15960716
[TBL] [Abstract][Full Text] [Related]
18. Implications of CJD data need to be clear before release.
Thornett A
BMJ; 2000 Sep; 321(7262):701. PubMed ID: 11202929
[No Abstract] [Full Text] [Related]
19. Classification of sporadic Creutzfeldt-Jakob disease revisited.
Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
[TBL] [Abstract][Full Text] [Related]
20. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1978-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1152-4. PubMed ID: 18946463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
